
zzso zzso zzso is the eighth most common cancer type worldwide with a dismal zzso zzso Barrett zzso the replacement of the normal zzso zzso with zzso cells, is the first step in the zzso towards zzso Although most patients with zzso present de zzso the presence of the easily zzso zzso precursor zzso Barrett zzso enables the possibility of early detection of high-risk patients who are more likely to zzso Currently, identification of high-risk patients depends on zzso assessment of zzso with no regards to molecular zzso In the future, screening and risk zzso initiatives for Barrett zzso that incorporate molecular profiles might permit improved early diagnosis and intervention strategies with the possibility of preventing zzso For the majority of patients presenting de zzso at an advanced stage, combining so-called zzso zzso with current clinical staging zzso might enable zzso to be better classified according to distinct molecular zzso thereby leading to better targeted treatment strategies as well as cancer monitoring zzso This Review discusses how the latest advances in zzso technologies have improved our understanding of the development and biology of zzso and how this development might alter patient management in the zzso 

